AM

Atish Madan Garg

Active Director Designated Partner DIN 07230628
DIN 07230628 First appointment Aug 2015 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Atish Madan Garg

Data last updated:

Atish Madan Garg is a Designated Partner at Heal Thy Self Pharmaceuticals Llp (since 2015). The company operates in Chemicals.

DIN 07230628
Primary Designation Designated Partner
Industry Chemicals
First Appointment 10 Aug 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Aug 20152015Active

Board colleagues of Atish Madan Garg

Directorship timeline

Open interactive timeline →
Heal Thy Self Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Atish Madan Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atish Madan Garg

Atish Madan Garg currently holds 1 directorship: Heal Thy Self Pharmaceuticals Llp (Designated Partner, since 10 Aug 2015).

Atish Madan Garg was first appointed on 10 Aug 2015 as Designated Partner at Heal Thy Self Pharmaceuticals Llp.

The current boards of Atish Madan Garg's companies include Abhishek Shriniwas Bansal (Heal Thy Self Pharmaceuticals Llp), Ankita Sharad Agarwal (Heal Thy Self Pharmaceuticals Llp), Meenal Shriniwas Bansal (Heal Thy Self Pharmaceuticals Llp), Sharad Ashok Agarwal (Heal Thy Self Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available